Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · IEX Real-Time Price · USD
4.12
-0.04 (-0.96%)
Dec 29, 2023, 4:30 PM EST - Market closed
Achieve Life Sciences Stock Forecast
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for ACHV stock stock is $18.5, which predicts an increase of 349.03%. The lowest target is $18 and the highest is $19. On average, analysts rate ACHV stock stock as a strong buy.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ACHV stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +336.89% | Dec 12, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $22 → $19 | Strong Buy | Maintains | $22 → $19 | +361.17% | May 31, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +433.98% | May 10, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 | Buy | Reiterates | $17 | +312.62% | Mar 17, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $21 → $8 | Strong Buy | Maintains | $21 → $8 | +94.17% | Nov 16, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.60
from -4.00
EPS Next Year
-1.37
from -1.60
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | 102.0M | 119.5M | 223.7M | 334.9M |
| Avg | n/a | n/a | 46.2M | 78.7M | 182.7M | 307.8M |
| Low | n/a | n/a | 1.8M | 39.7M | 142.3M | 278.9M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | 158.5% | 184.4% | 83.3% |
| Avg | - | - | - | 70.3% | 132.2% | 68.5% |
| Low | - | - | - | -14.1% | 80.8% | 52.7% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -1.61 | -1.13 | 2.35 | 1.00 | 5.41 | 11.55 |
| Avg | -1.60 | -1.37 | 0.00 | 0.64 | 4.29 | 8.21 |
| Low | -1.57 | -1.58 | -1.18 | 0.29 | 3.20 | 4.99 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | 39,017.6% | 748.2% | 169.0% |
| Avg | - | - | - | 24,900.0% | 573.6% | 91.1% |
| Low | - | - | - | 11,429.4% | 402.7% | 16.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.